Honghong Tan

670 total citations
18 papers, 559 citations indexed

About

Honghong Tan is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Pharmacology. According to data from OpenAlex, Honghong Tan has authored 18 papers receiving a total of 559 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 5 papers in Cardiology and Cardiovascular Medicine and 4 papers in Pharmacology. Recurrent topics in Honghong Tan's work include Pharmacogenetics and Drug Metabolism (4 papers), Macrophage Migration Inhibitory Factor (3 papers) and Tissue Engineering and Regenerative Medicine (2 papers). Honghong Tan is often cited by papers focused on Pharmacogenetics and Drug Metabolism (4 papers), Macrophage Migration Inhibitory Factor (3 papers) and Tissue Engineering and Regenerative Medicine (2 papers). Honghong Tan collaborates with scholars based in China and United States. Honghong Tan's co-authors include Lin Jiang, Jing Xiao, Xiaojun Yang, Xuemei Yu, Juan Feng, Yuliang Feng, Yu Pan, Qiu‐Xiong Lin, Zhi‐Xin Shan and Yong‐Heng Fu and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Cell Death and Disease.

In The Last Decade

Honghong Tan

18 papers receiving 556 citations

Peers

Honghong Tan

CCM

SURGE

PHARM

Yuexiu Wu Canada

Bofang Zhang China

Xiaosheng Hu China

Zhongwen Qi China

Chungang Zhai China

Paola Perrotta Belgium

Shuohui Dong China

Mini Chandra India

Yingqiang Du China

Yuexiu Wu Canada

Honghong Tan

471 ×1.3

287 ×1.4

53 ×0.4

CCM

91 ×1.1

SURGE

38 ×0.8

PHARM

Citations per year, relative to Honghong Tan Honghong Tan (= 1×) peers Yuexiu Wu

Countries citing papers authored by Honghong Tan

Since Specialization

Citations

This map shows the geographic impact of Honghong Tan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Honghong Tan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Honghong Tan more than expected).

Fields of papers citing papers by Honghong Tan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Honghong Tan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Honghong Tan. The network helps show where Honghong Tan may publish in the future.

Co-authorship network of co-authors of Honghong Tan

This figure shows the co-authorship network connecting the top 25 collaborators of Honghong Tan. A scholar is included among the top collaborators of Honghong Tan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Honghong Tan. Honghong Tan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Shi, Xinyu, et al.. (2024). Nanoengineering‐armed oncolytic viruses drive antitumor response: progress and challenges. SHILAP Revista de lepidopterología. 5(10). e755–e755. 6 indexed citations

Cai, Shi‐Ying, et al.. (2023). Characterization of gut microbiota in patients with stage 3–4 chronic kidney disease: a retrospective cohort study. International Urology and Nephrology. 56(5). 1751–1762. 6 indexed citations

Qu, Xiao, Honghong Tan, Mengxue Yang, et al.. (2022). Identification of a novel prognostic signature correlated with epithelial‐mesenchymal transition, N6‐methyladenosine modification, and immune infiltration in colorectal cancer. Cancer Medicine. 12(5). 5926–5938. 6 indexed citations

Xiao, Jing, Yu Pan, Xiaojun Yang, et al.. (2016). Cardiac progenitor cell-derived exosomes prevent cardiomyocytes apoptosis through exosomal miR-21 by targeting PDCD4. Cell Death and Disease. 7(6). e2277–e2277. 306 indexed citations

Li, Qianqian, Lin Jiang, Chunyu Deng, et al.. (2015). Generation of Functional Human Cardiac Progenitor Cells by High-Efficiency Protein Transduction. Stem Cells Translational Medicine. 4(12). 1415–1424. 36 indexed citations

Lin, Qiu‐Xiong, Jie-Ning Zhu, Xiaohong Li, et al.. (2014). The caspase-8 shRNA-modified mesenchymal stem cells improve the function of infarcted heart. Molecular and Cellular Biochemistry. 397(1-2). 7–16. 19 indexed citations

Zhang, Qianhuan, Chunyu Deng, Fang Rao, et al.. (2013). Silencing of desmoplakin decreases connexin43/Nav1.5 expression and sodium current in HL-1 cardiomyocytes. Molecular Medicine Reports. 8(3). 780–786. 29 indexed citations

Lei, Heping, Hongmei Chen, Shilong Zhong, et al.. (2012). Association between polymorphisms of the renin–angiotensin system and coronary artery disease in Chinese patients with type 2 diabetes. Journal of the Renin-Angiotensin-Aldosterone System. 13(2). 305–313. 13 indexed citations

Liu, Yuan, et al.. (2011). [Distribution of variant alleles association with warfarin pharmacokinetics and pharmacodynamics in the Han population in China].. PubMed. 43(6). 798–803. 4 indexed citations

10.

Zhong, Shilong, Yuan Liu, Xi‐Yong Yu, et al.. (2011). The influence of genetic polymorphisms and interacting drugs on initial response to warfarin in Chinese patients with heart valve replacement. European Journal of Clinical Pharmacology. 67(6). 581–590. 12 indexed citations

11.

Zhong, Shilong, Yuan Liu, Dan Xu, et al.. (2011). Integrating interacting drugs and genetic variations to improve the predictability of warfarin maintenance dose in Chinese patients. Pharmacogenetics and Genomics. 22(3). 176–182. 33 indexed citations

12.

Yu, Xi‐Yong, Hongmei Chen, Jialiang Liang, et al.. (2011). Hyperglycemic Myocardial Damage Is Mediated by Proinflammatory Cytokine: Macrophage Migration Inhibitory Factor. PLoS ONE. 6(1). e16239–e16239. 48 indexed citations

13.

Liu, Yuan, et al.. (2011). [Impact of CYP2C9 and VKORC1 polymorphism on warfarin response during initiation of therapy].. PubMed. 39(10). 929–35. 5 indexed citations

14.

Liu, Yuan, Shilong Zhong, Min Yang, et al.. (2010). [Clinical application of anticoagulation treatment with warfarin after prosthetic heart valve replacement: a single center-based survey].. PubMed. 30(10). 2242–5. 1 indexed citations

15.

Chen, Hongmei, et al.. (2010). [High glucose up-regulates GRK2 gene expression in H9C2 cardiomyoblasts in vitro].. PubMed. 30(3). 472–4. 2 indexed citations

16.

Lin, Qiu‐Xiong, Chunyu Deng, Honghong Tan, et al.. (2009). [Identification of the interactions between the truncated fragments of macrophage migration inhibitory factor and CD74 using a yeast two-hybrid system].. PubMed. 29(12). 2383–6, 2390. 2 indexed citations

17.

Shan, Zhi‐Xin, Qiu‐Xiong Lin, Chunyu Deng, et al.. (2008). An efficient method to enhance gene silencing by using precursor microRNA designed small hairpin RNAs. Molecular Biology Reports. 36(6). 1483–1489. 21 indexed citations

18.

Shan, Zhi‐Xin, Yong‐Heng Fu, Chunyu Deng, et al.. (2006). [Association of the polymorphism of macrophage migration inhibitory factor gene with coronary heart disease in Chinese population].. PubMed. 23(5). 548–50. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact